What is the appropriate management of a 37‑week pregnant patient presenting with per vaginal bleeding?

Management of Per Vaginal Bleeding at 37 Weeks Gestation

Immediately perform transabdominal ultrasound followed by transvaginal ultrasound to identify the bleeding source, and avoid digital vaginal examination until placenta previa and vasa previa are definitively excluded. 1

Initial Assessment and Critical Safety Measure

At 37 weeks gestation with vaginal bleeding, your first priority is determining the etiology while protecting both maternal and fetal life. Digital pelvic examination is absolutely contraindicated until ultrasound excludes placenta previa, low-lying placenta, and vasa previa 1. This is non-negotiable—digital examination with an undiagnosed previa can precipitate catastrophic hemorrhage.

Immediate Diagnostic Approach

Start with transabdominal ultrasound as the primary imaging modality, then proceed to transvaginal ultrasound for definitive diagnosis 1. The 2020 ACR Appropriateness Criteria establish that transvaginal ultrasound is superior to transabdominal and transperineal approaches and is safe even with suspected previa 1. Transvaginal scanning provides optimal visualization of the cervix and placental edge relationship to the internal os 1.

Differential Diagnosis by Likelihood at 37 Weeks

The bleeding etiology determines your management pathway:

Most Common Causes:

• "Bloody show" (physiologic): Normal cervical change preceding labor—this is the most benign explanation at term
• Placenta previa: Affects 1 in 200 pregnancies at delivery 1
• Placental abruption: Affects ~1% of pregnancies, though ultrasound only detects ≤50% of cases 1

Life-Threatening Causes to Rule Out:

• Vasa previa: Rare (1 in 2,500-5,000 deliveries) but can cause fetal exsanguination 1
• Uterine rupture: Rare but consider with prior cesarean or uterine surgery 1

Less Common:

• Cervical causes (cervicitis, polyp, laceration)
• Vaginal laceration

Management Algorithm Based on Ultrasound Findings

If Placenta Previa Confirmed:

Deliver at 36-37 6/7 weeks for stable women without active bleeding 2. At 37 weeks, you're already in the recommended delivery window. The 2018 SMFM guidelines are explicit: delivery between 36-37 6/7 weeks for stable placenta previa 2.

• With active hemorrhage: Proceed to immediate cesarean delivery; do not delay for corticosteroids 2
• Stable without active bleeding: Schedule cesarean delivery within days
• Ensure cross-matched blood available and have massive transfusion protocol ready

If Placenta Accreta Suspected:

Deliver between 34-37 weeks for stable patients 2. At 37 weeks with bleeding, proceed to planned cesarean hysterectomy with appropriate surgical team (consider MFM, gynecologic oncology, urology backup).

If Vasa Previa Identified:

Deliver between 34-37 weeks for stable patients 2. At 37 weeks with any bleeding, this is an obstetric emergency—proceed to immediate cesarean delivery before membrane rupture causes fetal exsanguination.

If Placental Abruption Suspected:

Ultrasound is insensitive (detects <50% of cases) 1. Do not delay management waiting for ultrasound confirmation 3. Clinical diagnosis based on:

• Vaginal bleeding with abdominal pain
• Uterine tenderness or contractions
• Abnormal fetal heart rate pattern

Management: Rapid assessment of maternal hemodynamic status and fetal well-being. At 37 weeks with significant abruption, proceed to delivery—vaginal if stable and progressing, cesarean if maternal/fetal compromise.

If "Bloody Show" or Benign Cervical Cause:

With normal placental location, reassuring fetal status, and minimal bleeding:

• Speculum examination is now safe to visualize cervix
• Assess for cervical dilation/effacement
• If in early labor at term, proceed with routine labor management

Critical Interventions During Active Hemorrhage

Regardless of cause, with significant bleeding:

1. Hemodynamic stabilization takes priority:

   • Two large-bore IVs (14-16 gauge) 3
   • Aggressive fluid resuscitation
   • Type and cross-match; transfuse O-negative if needed urgently 3
   • Coagulation panel including fibrinogen 3

2. Maternal positioning: Left lateral tilt or manual uterine displacement to prevent aortocaval compression 3

3. Oxygen supplementation: Maintain maternal saturation >95% 3

4. Continuous fetal monitoring if not proceeding immediately to delivery

5. Do NOT use vasopressors unless hypotension is refractory to fluids—they compromise uteroplacental perfusion 3

Corticosteroid Consideration

At 37 weeks, do not administer corticosteroids. The RCOG guidelines recommend steroids between 34+0 and 35+6 weeks for placenta previa 4. The SMFM is explicit: with active hemorrhage requiring delivery, do not delay for corticosteroids 2. At 37 weeks, you're beyond the window where steroids provide benefit.

Rh Status Management

If patient is Rh-negative, administer anti-D immunoglobulin immediately 3. Perform Kleihauer-Betke test to quantify fetomaternal hemorrhage and determine if additional doses are needed 3.

Common Pitfalls to Avoid

• Never perform digital examination before ultrasound excludes previa—this single error can cause maternal death
• Don't rely on ultrasound alone to exclude abruption—clinical diagnosis is paramount 3
• Don't delay delivery at 37 weeks for "expectant management" with diagnosed previa/accreta/vasa previa—you're already at recommended delivery timing 2
• Don't use tocolytics if delivery is indicated based on maternal/fetal concerns 4